Medical Science

  • Home

Volume 29, Issue 163, September 2025

Sarcopenia in Patients with Chronic Kidney Diseases

Maria Anna Żmijewska1, Natalia Katarzyna Wagner-Bieleń2♦, Martyna Zwierzchowska3, Agata Antoniak4, Anna Maria Jocz5, Anna Centkowska6, Joanna Karina Banaśkiewicz7, Aleksandra Maria Żyta3, Gabriela Helena Dąbrowska8, Jakub Ziółkowski3

1Faculty of Medicine, Medical University of Warsaw, ul. Żwirki i Wigury 61, 02-091 Warsaw, Poland
2Military Institute of Medicine - National Research Institute, ul. Szaserów 128, 04-141 Warsaw, Poland
3Independent Public Clinical Hospital of Prof. W. Orlowski CMKP, ul. Czerniakowska 231, 00-416 Warsaw, Poland
4Praski Hospital of the Transfiguration of the Lord, al. "Solidarności" 67, 03-401 Warsaw, Poland
5Specialist Provincial Hospital in Ciechanów, Powstańców Wielkopolskich 2, 06-400 Ciechanów, Poland
6Wolski Hospital of Dr. Anna Gostyńska, ul. Marcina Kasprzaka 17, 01-211 Warsaw, Poland
7Independent Public Health Care Complex - Hospital in Iłża, ul. Bodzentyńska 17, 27-100 Iłża, Poland
8The Infant Jesus Teaching Hospital, ul. Williama Heerleina Lindleya 4, 02-005 Warsaw, Poland

♦Corresponding author
Natalia Katarzyna Wagner-Bieleń Military Institute of Medicine - National Research Institute ul. Szaserów 128, 04-141 Warsaw, Poland

ABSTRACT

Background: Sarcopenia, characterized by a progressive decrease in skeletal muscle mass and decline in muscle function, is a common factor amongst patients with chronic kidney disease (CKD). Purpose of review: This narrative review summarizes the most recent evidence regarding the epidemiology, pathophysiology, clinical implications, diagnostic criteria, and therapeutic strategies for sarcopenia in CKD patients. Methods: The study used a recent literature synthesis method. Results: 25-50% of patients with CKD have the presence of sarcopenia. Major contributors are chronic inflammation, oxidative stress, and alterations in hormone signaling. It has been advocated that muscle strength is a more reliable predictor of poor outcomes than muscle mass. Conclusion: Early recognition and an organized approach play an important role in enhancing their clinical course.

Keywords: Sarcopenia, chronic kidney disease, muscle strength, renal rehabilitation, inflammation

Medical Science, 2025, 29, e172ms3710
PDF
DOI: https://doi.org/10.54905/disssi.v29i163.e172ms3710

Published: 21 September 2025

Creative Commons License

© The Author(s) 2025. Open Access. This article is licensed under a Creative Commons Attribution License 4.0 (CC BY 4.0).